Human Gene Mutations Affecting RNA Processing and Translation

References

• Atwater J A., Wisdom R, Verma I M. Regulated mRNA stability. Annu Rev Genet 1990; 24: 519–41
   PubMed Web of Science ®Google Scholar
• Hentze M W. Determinants and regulation of cytoplasmic mRNA stability in eukaryotic cells. Biochim Biophys Acta 1991; 1090: 281–92
   PubMed Web of Science ®Google Scholar
• Cooper D N. Regulatory mutations and human genetic disease. Ann Med 1992; 24: 427–38
   PubMed Web of Science ®Google Scholar
• Krawczak M, Reiss J, Cooper D N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90: 41–54
   PubMed Web of Science ®Google Scholar
• Wong C, Dowling C E., Saiki R K., Higuchi R, Erlich H A., Kazazian H H. Characterization of β-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA. Nature 1987; 330: 384–6
   PubMed Web of Science ®Google Scholar
• Kozak M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res 1984; 12: 857–72
   PubMed Web of Science ®Google Scholar
• Myers R M., Tilly K, Maniatfs T. Fine structure genetic, analysis of a β-globin promoter. Science 1986; 232: 613–8
   PubMed Web of Science ®Google Scholar
• Wahle E. The end of the message: 3'-end processing leading to polyadenylated messenger RNA. BioEssays 1992; 14: 113–8
   PubMedGoogle Scholar
• Orkin S H., Cheng T C., Antonarakis S E., Kazazian H H. Thalassemia due to a mutation in the cleavage-polyadenylation signal of the human β-globin gene. EMBO J 1985; 4: 453–6
   PubMed Web of Science ®Google Scholar
• Jankovic L, Efremov G D., Petkov G, et al. Two novel polyadenylation mutations leading to β+-thalassaemia. Br J Haematol 1990; 75: 122–6
   PubMed Web of Science ®Google Scholar
• Kazazian H H., Boehm C D. Molecular basis and prenatal diagnosis of β-thalassaemia. Blood 1988; 72: 1107–16
   PubMed Web of Science ®Google Scholar
• Rund D, Dowling C, Najjar K, Rachmilewltz E A., Kazazian H H., Oppenheim A. Two mutations in the β-globin polyadenylation signal reveal extended transcripts and new RNA polyadenylation sites. Proc Natl Acad Sci USA 1992; 89: 4324–28
   PubMed Web of Science ®Google Scholar
• Higgs D R., Goodbourn S EY, Lamb J, Clegg J B., Weatherall D J. Alpha-thalassaemia caused by a polyadenylation signal mutation. Nature 1983; 306: 398–400
   PubMed Web of Science ®Google Scholar
• Theln S L., Wallace R B., Pressley L, Clegg J B., Weatherall D J., Hlggs D R. The polyadenylation site mutation in the alpha-globin gene cluster. Blood 1988; 71: 313–9
   PubMedGoogle Scholar
• Yüregir G T., Aksoy K, Çürük M A., et al. Hb H disease in a Turkish family resulting from the interaction of a deletional alpha-thalassaemia-1 and a newly discovered poly A mutation. Br J Haematol 1992; 80: 527–32
   PubMed Web of Science ®Google Scholar
• Cal S P., Eng B, Francombe W H., et al. Two novel β-thalassaemia mutations in the 5' and 3' noncoding regions of the β-globin gene. Blood 1992; 79: 1342–6
   PubMedGoogle Scholar
• Clegg J B., Weatherall D J., Mllner P G. Haemoglobin Constant Spring-a chain termination mutant?. Nature 1971; 234: 337–40
   PubMed Web of Science ®Google Scholar
• Mllner P F., Clegg J B., Weatherall D J. Haemoglobin H disease due to a unique haemoglobin variant with an elongated alpha chain. Lancet 1971; i: 729–32
   Google Scholar
• Hunt D M., Hlggs D R., Winlchagoon P, Clegg J B., Weatherall D J. Haemoglobin Constant Spring has an unstable alpha chain messenger RNA. Br J Haematol 1982; 51: 405–13
   PubMed Web of Science ®Google Scholar
• Derry S, Wood W G., Plppard M, et al. Hematologic and biosynthetic studies in homozygous hemoglobin Constant Spring. J Clin Invest 1984; 73: 1673–82
   PubMed Web of Science ®Google Scholar
• Bunn H F. Mutant hemoglobins having elongated chains. Hemoglobin 1978; 2: 1978–87
   Google Scholar
• Clegg J B., Weatherall D J., Contopoulos-Griva I, Caroutsos K, Poungouras P, Tsevrenis H. Haemoglobin Icaria, a new chain termination mutant which causes alpha-thalassaemia. Nature 1974; 251: 245–8
   PubMed Web of Science ®Google Scholar
• De Jong W W., Khan P M., Bernini L F. Hemoglobin Koya Dora: high frequency of a chain termination mutant. Am J Hum Genet 1975; 27: 81–7
   PubMed Web of Science ®Google Scholar
• Bradley T B., Wohl R C., Smith G J. Elongation of the alpha globin chain in a black family: interaction with Hb G Philadelphia. Clin Res 1975; 23: 1314–9
   Google Scholar
• Berls P H., Miesher P A., Dlaz-Chico J C., et al. Inclusion body β-thalassaemia trait in a Swiss family is caused by an abnormal hemoglobin (Geneva) with an altered and extended β-chain carboxy terminus due to a modification in codon β 114. Blood 1988; 72: 801–7
   PubMedGoogle Scholar
• Rlstaldl M S., Plrastu M, Murru S, et al. A spontaneous mutation produced a novel elongated β-globin chain structural variant (Hb Agnana) with a thalassemia-like phenotype. Blood 1990; 75: 1378–80
   PubMedGoogle Scholar
• Kazazlan H H., Dowling C E., Hurwltz R L., Coleman M, Adams J G. Thalassemia mutations in exon 3 of the β-globin gene often cause a dominant form of thalassemia and show no predilection for malarial-endemic regions of the world. Am J Hum Genet 1989; 25(Suppl)950
   Google Scholar
• Fucharoen S, Kobayashl Y, Fucharoen G, et al. A single nucleotide deletion in codon 123 of the β-globin gene causes an inclusion body β-thalassaemia trait: a novel elongated globin chain β Makabe. Br J Haematol 1990; 75: 393–9
   PubMed Web of Science ®Google Scholar
• Theln S L., Hesketh C, Taylor P, et al. Molecular basis for dominantly inherited inclusion body β-thalassemia. Proc Natl Acad Sci USA 1990; 87: 3924–8
   PubMedGoogle Scholar
• Murru S, Loudlanos G, Deiana M, et al. Molecular characterization of β-thalassaemia intermedia in patients of Italian descent and identification of three novel β-thalassemia mutations. Blood 1991; 77: 1342–7
   PubMed Web of Science ®Google Scholar
• Patten J L., Johns D R., Valle D, et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 1990; 322: 1412–8
   PubMedGoogle Scholar
• Fojo S S., Van den Chapman J, et al. An initiation codon mutation in the ApoC-II gene (ApoC-II Paris) of a patient with a deficiency of apolipoprotein C-II. J Biol Chem 1989; 264: 20839–42
   PubMedGoogle Scholar
• Mitchell G A., Brody L C., Looney J, et al. An initiator codon mutation in ornithine-delta-aminotransferase causing gyrate atrophy of the choroid and retina. J Clin Invest 1988; 81: 630–3
   PubMedGoogle Scholar
• Tarlé S A., Davidson B L., Wu V C., et al. Determination of the mutations responsible for the Lesch-Nyhan syndrome in 17 subjects. Genomics 1991; 10: 499–501
   PubMedGoogle Scholar
• Sligh J E., Hurwltz M Y., Zhu C, Anderson D C., Beaudet A L. An initiation codon mutation in CD 18 in association with the moderate phenotype of leukocyte adhesion deficiency. J Biol Chem 1992; 267: 714–8
   PubMed Web of Science ®Google Scholar
• John S W., Rozen R, Laframboise R, Laberge C, Scriver C R. Novel PKU mutation on haplotype 2 in French-Canadians. Am J Hum Genet 1989; 45: 905–9
   PubMedGoogle Scholar
• Schnabel D, Schröder M, Fürst W, et al. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J Biol Chem 1992; 267: 3312–5
   PubMed Web of Science ®Google Scholar
• Mules E H., Hayfllck S, Miller C S., Reynolds L W., Thomas G H. Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals. Am J Hum Genet 1992; 50: 834–41
   PubMedGoogle Scholar
• Plrastu M, Saglio G, Chang J C., Cao A, Kan Y W. Initiation codon mutation as a cause of alpha thalassamia. J Biol Chem 1984; 259: 12315–7
   PubMedGoogle Scholar
• Moi P, Cash F E., Liebhaber S A., Cao A, Pirastu M. An initiation codon mutation (AUG GUG) of the human alphal-globin gene. J Clin Invest 1987; 80: 1416–21
   PubMed Web of Science ®Google Scholar
• Lam V MS, Xie S S., Tarn J WO, Woo Y K., Gu Y L., LI A MC. A new single nucleotide change at the initiation codon (ATG-AGG) identified in amplified genomic DNA of a Chinese β-thalassemic patient. Blood 1990; 75: 1207–8
   PubMed Web of Science ®Google Scholar
• Hattorl Y, Yamashiro Y, Ohba Y, et al. A new beta-thalassemia mutation (initiation codon ATG GTG) found in the Japanese population. Hemoglobin 1991; 15: 317–25
   PubMedGoogle Scholar
• Morlé F, Lopez B, Henni T, Godet J. Alpha-thalassemia associated with the deletion of two nucleotides at position-2 and-3 preceding the AUG codon. EMBO J 1985; 4: 1245–50
   PubMedGoogle Scholar
• Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 1991; 266: 19867–70
   PubMed Web of Science ®Google Scholar
• Neote K, Brown C A., Mahuran D J., Gravel R A. Translation initiation in the HEXB gene encoding the beta-subunit of human β-hexasaminidase. J Biol Chem 1990; 265: 20799–806
   PubMedGoogle Scholar
• Benz E J., Forget B G., Hillman D G., et al. Variability in the amount of β thalassemia. Cell 1978; 14: 299–304
   PubMedGoogle Scholar
• Fojo S S., Lohse P, Parrott C, et al. A nonsense mutation in the apolipoprotein C-ll Padova gene in a patient with apolipoprotein C-ll deficiency. J Clin Invest 1989; 84: 1215–9
   PubMed Web of Science ®Google Scholar
• Hamosh A, Trapnell B C., Zeitlin P L., et al. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J Clin Invest 1991; 88: 1880–5
   PubMedGoogle Scholar
• Frangl D, Cicardl M, Sica A, Colotta F, Agostoni A, Davis A E. Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type 1 hereditary angioneurotic edema. J Clin Invest 1991; 88: 755–9
   PubMedGoogle Scholar
• Liebhaber S A., Coleman M B., Adams J G., Cash F E., Steinberg M H. Molecular basis for nondeletion alpha-thalassaemia in American blacks; alpha2 116 GAG UAG. J Clin Invest 1987; 80: 154–9
   PubMed Web of Science ®Google Scholar
• Chang J C., Kan Y W. β thalassemia, a nonsense mutation in man. Proc Natl Acad Sci USA 1979; 76: 2886–9
   PubMed Web of Science ®Google Scholar
• Trecartin R F., Liebhaber S A., Chang J C., et al. β thalassemia in Sardinia is caused by a nonsense mutation. J Clin Invest 1981; 68: 1012–7
   PubMed Web of Science ®Google Scholar
• Atweh G F., Brickner H E., Zhu X X., Kazazian H H., Forget B G. New amber mutation in a β-thalassemic gene with nonmeasurable levels of mutant messenger RNA in vivo. J Clin Invest 1988; 82: 557–61
   PubMed Web of Science ®Google Scholar
• Kinniburgh A J., Maquat L E., Schedl T, Rachmilewitz E, Ross J. mRNA-deficient β thalassemia results from a single nucleotide deletion. Nucleic Acids Res 1982; 10: 5421–7
   PubMed Web of Science ®Google Scholar
• Adams J G., Steinberg M H., Kazazian H H. Isolation and characterization of the translation product of a β-globin gene nonsense mutation (β 121 GAA-TAA). Br J Haematol 1990; 75: 561–7
   PubMedGoogle Scholar
• Winslow R M., Swenberg M L., Gross E, Chervenick P A., Buchman R R., Anderson W F. Hemoglobin McKees Rocks (alpha2beta2 145 Tyr-Term). A human nonsense mutation leading to a shortened β-chain. J Clin Invest 1976; 57: 772–81
   PubMed Web of Science ®Google Scholar
• Longo N, Langley S D., Griffin L D., Elsas L J. Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance. Am J Hum Genet 1992; 50: 998–1007
   PubMedGoogle Scholar
• Lehrman M A., Schneider W J., Brown M S., et al. The Lebanese allele at the low density lipoprotein receptor locus. J Biol Chem 1987; 262: 401–10
   PubMed Web of Science ®Google Scholar
• Mashima Y, Murakami A, Weleber R G., et al. Nonsensecodon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am J Hum Genet 1992; 51: 81–91
   PubMed Web of Science ®Google Scholar
• Akaki Y, Hotta Y, Mashima Y, et al. A deletion in the ornithine aminotransferase gene in gyrate atrophy. J Biol Chem 1992; 267: 12950–4
   PubMedGoogle Scholar
• Daar I O., Maquat L E. Premature translation termination mediates triosephosphate isomerase mRNA degradation. Mol Cell Biol 1988; 8: 802–13
   PubMed Web of Science ®Google Scholar
• Eikenboom J CJ, Van den Amstel H. Severe type III von Willebrand's disease in the Dutch population is often associated with the absence of von Willebrand factor messenger RNA. Thromb Haemost 1991; 65: 1127
   Google Scholar
• Takeshita K, Forget B G., Scarpa A, Benz E J. Intranuclear defect in β-globin mRNA accumulation due to a premature translation termination codon. Blood 1984; 64: 13–22
   PubMed Web of Science ®Google Scholar
• Humphries K R., Ley T J., Anagnou N P., Baur A W., Nienhuis A W. β-39 thalassemia gene: a premature termination codon causes β-mRNA deficiency without affecting cytoplasmic β-mRNA stability. Blood 1984; 64: 23–32
   PubMed Web of Science ®Google Scholar
• Baserga S J., Benz E J. Nonsense mutations in the human β-globin gene affect mRNA metabolism. Proc Natl Acad Sci USA 1988; 85: 2056–60
   PubMed Web of Science ®Google Scholar
• Baserga S J., Benz E J. β-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability. Proc Natl Acad Sci USA 1992; 89: 2935–9
   PubMedGoogle Scholar
• Losson R, Lacroute F. Interference of nonsense mutations with eukaryotic messenger RNA stability. Proc Natl Acad Sci USA 1979; 76: 5134–7
   PubMed Web of Science ®Google Scholar
• Maquat L E., Kinniburgh A J., Rachmilewitz E A., Ross J. Unstable beta-globin mRNA in mRNA-deficient β-thalassemia. Cell 1981; 27: 543–53
   PubMed Web of Science ®Google Scholar
• Urlaub G, Mitchell P J., Ciudad C J., Chasin L A. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol 1989; 9: 2868–80
   PubMedGoogle Scholar
• Cheng J, Fogel-Petrovic M, Maquat L E. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA. Mol Cell Biol 1990; 10: 5215–25
   PubMedGoogle Scholar
• Hesketh J E., Pryne I F. Interaction between mRNA, ribosomes and the cytoskeleton. Biochem J 1991; 277: 1–10
   PubMedGoogle Scholar
• Lim S K., Sigmund C D., Gross K W., Maquat L E. Nonsense codonsin human β-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol 1992; 12: 1149–61
   PubMedGoogle Scholar
• Ploos van Amstel H K., Diepstraten C M., Reitsma P H., Bertina R M. Analysis of platelet protein S mRNA suggests silent alleles as a frequent cause of hereditary protein S deficiency type l. Thromb Haemost 1991; 65: 808
   Google Scholar
• Peerlinck K, Eikenboom J CJ, Van den Amstel H K., et al. A patient with von Willebrand's disease characterized by compound heterozygosity for a substitution of Arg 854 by Gin in the putative factor VIII-binding domain of von Willebrand factor on one allele and very low levels of mRNA from the second allele. Br J Haematol 1992; 80: 358–63
   PubMedGoogle Scholar